Skip to main content

Extending RNA Technology Pipelines into New Tissues and Applications

October 17, 2023
Imperial Ballroom
Within the past five years, RNA technologies have demonstrated they can improve patients' health by transforming gene expression and open a successful new frontier for infectious disease vaccine development as seen fighting COVID-19. Companies are pushing RNA-based therapeutics into new tissues of the body beyond the liver and expanding vaccine programs to fight cancer and non-infectious diseases. This session will map out the RNA technology pipelines demonstrating clinical progress and feature experts describing the R&D hurdles they are still working to overcome.
Andrew Allen, Co-founder, President and Chief Executive Officer - Gritstone
Zhen Li, President & CEO - ADARx Pharmaceuticals
Charles Allerson, SVP of Chemistry - DTx Pharma